triamcinolone has been researched along with dihydrotestosterone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fenard, O; Kern, P; Loire, C; Sultan, C; Terraza, A | 1 |
Nicholson, WE; Orth, DN; Watanabe, H | 1 |
Brive, L; Ely, KR; Feldman, D; Krishnan, AV; Peehl, DM; Swami, S; Zhao, XY | 1 |
1 review(s) available for triamcinolone and dihydrotestosterone
Article | Year |
---|---|
[Collagen and steroid hormones].
Topics: Androgens; Animals; Cells, Cultured; Collagen; Dihydrotestosterone; Estrogens; Fibroblasts; Glucocorticoids; Humans; Hydrocortisone; Procollagen; Procollagen-Proline Dioxygenase; Triamcinolone | 1986 |
2 other study(ies) available for triamcinolone and dihydrotestosterone
Article | Year |
---|---|
Inhibition of adrenocorticotropic hormone production by glucocorticoids in mouse pituitary tumor cells.
Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; Biological Assay; Cell Line; Clone Cells; Corticosterone; Desoxycorticosterone; Dexamethasone; Dihydrotestosterone; Estradiol; Feedback; Glucocorticoids; Hydrocortisone; In Vitro Techniques; Mice; Pituitary Gland; Pituitary Neoplasms; Progesterone; Rats; Testosterone; Triamcinolone | 1973 |
A glucocorticoid-responsive mutant androgen receptor exhibits unique ligand specificity: therapeutic implications for androgen-independent prostate cancer.
Topics: Androgen Antagonists; Androgens; Anilides; Binding, Competitive; Cell Line; Dihydrotestosterone; Fludrocortisone; Genes, Reporter; Glucocorticoids; Humans; Hydrocortisone; Kinetics; Ligands; Male; Mifepristone; Models, Molecular; Mutation; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Radioligand Assay; Receptors, Androgen; Tosyl Compounds; Triamcinolone | 2002 |